• Specific subtypes of voltage gated sodium channels (Nav1.1-1.9) linked to inflammatory and nociceptive pain.• Pharmacokinetic studies reveal misconceived drug interactions with oxcarbazepine• Carbamazepine and oxcarbazepine may be currently underutilized for certain pain syndromes.• There is a call for additional research for carboxamide subclass of sodium channel blockers in pain
from The Journal of Pain http://ift.tt/2xqN4se
via IFTTT
No comments:
Post a Comment